Clinical Practice Guidelines for the Use of G-CSF 2022 and related articles

Articles (9 in this collection)

1. Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology

   Authors (first, second and last of 27)

   • Yuho Najima
   • Tomoya Maeda
   • Shingo Yano

   • Content type: Special Article
   • Published: 17 May 2024

   

2. Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology

   Authors (first, second and last of 27)

   • Kenji Tsuchihashi
   • Mamoru Ito
   • Eishi Baba

   • Content type: Special Article
   • Published: 02 May 2024

   

3. Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022

   Authors (first, second and last of 27)

   • Tetsuhiro Yoshinami
   • Kazuki Nozawa
   • Toshimi Takano

   • Content type: Special Article
   • Published: 23 April 2024

   

4. Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology

   Authors (first, second and last of 27)

   • Mamoru Ito
   • Yuta Okumura
   • Kenji Tsuchihashi

   • Content type: Special Article
   • Published: 05 April 2024

   

5. Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022

   Authors (first, second and last of 28)

   • Shoji Kimura
   • Keisuke Shigeta
   • Yuji Miura

   • Content type: Special Article
   • Published: 28 March 2024

   • Pages: 559 - 563

6. Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022

   Authors (first, second and last of 27)

   • Yukinori Ozaki
   • Takamichi Yokoe
   • Toshimi Takano

   • Content type: Special Article
   • Published: 25 March 2024

   • Pages: 551 - 558

   

7. Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022

   Authors (first, second and last of 28)

   • Keita Uchino
   • Shingo Tamura
   • Yuji Miura

   • Content type: Special Article
   • Published: 22 March 2024

   • Pages: 545 - 550

   

8. Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology

   Authors (first, second and last of 27)

   • Tomoya Maeda
   • Yuho Najima
   • Shingo Yano

   • Content type: Special Article
   • Open Access
   • Published: 18 March 2024

   • Pages: 535 - 544

   

9. Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022

   Authors (first, second and last of 28)

   • Eiki Ichihara
   • Nobuaki Ochi
   • Toshio Kubo

   • Content type: Special Article
   • Published: 14 February 2024

   • Pages: 355 - 362